Health Innovation
5 Early-Stage Health Startups Built Around Existing Care Workflows
DealBio tracks early-stage health startups across Europe and North America. These 5 are building around care workflows that patients, clinicians and hospitals already use.
- Provider Workflow
- Digital Health
- Clinical AI
- Chronic Care
Health technology becomes more useful when it fits naturally into care delivery. These startups are built around signals, reports, prescribing pathways, monitoring tasks and hospital processes that already have a clear place in the patient journey.
The opportunity is to strengthen an existing decision or process, whether that means identifying stroke risk, prioritizing rheumatology follow-up, verifying surgical trays, structuring home blood-pressure data or delivering prescribed insomnia treatment.
At a Glance
- OneCareAISpain2024Stroke risk from ECG
- Mana MedicalUnited Kingdom2023Rheumatology monitoring
- enamentisGermany2024Hospital sterile processing
- HealthNestUnited Kingdom2024Home blood-pressure monitoring
- Di & CareFrance2023Prescribed insomnia treatment
Developing AI software to estimate stroke risk from ECG recordings.
- Country
Spain- Founded
- 2024
- Sector
- Digital health
- Funding stage
- Seed or earlier
- Founders
Why OneCareAI stands out
OneCareAI reports clinical validation and pilots with three hospitals in Spain and Italy. Its GALEN technology originated at the Barcelona Supercomputing Center before being transferred into the startup.
The software uses an existing cardiovascular signal rather than introducing a new test. Its fit with the article thesis is direct: stroke-risk estimation is added to an ECG workflow clinicians already use, rather than requiring a separate diagnostic pathway.
What OneCareAI is building
INVICTUS uses the GALEN AI model to estimate stroke risk from a single ECG and can combine the trace with genetic, molecular, clinical and lifestyle data.
The platform is designed to run on conventional ECG machines and compatible wearables, giving clinicians a risk layer without replacing existing monitoring hardware.
Using wearable data to guide daily activity for people with inflammatory arthritis.
- Country
United Kingdom- Founded
- 2023
- Sector
- Digital health
- Funding stage
- Seed or earlier
- Founders
Why Mana Medical stands out
Mana Medical received pre-seed investment from Zinc Ventures and is running an eight-week beta study with recruitment support from the National Rheumatoid Arthritis Society.
The startup has built both a patient product and a clinician dashboard. That puts Mana Medical inside an existing rheumatology workflow, using patient-generated data to support daily self-management and help clinicians decide who may need attention first.
What Mana Medical is building
Patients connect an existing wearable and complete a short symptom check-in. Machine learning combines those inputs into personalized activity and pacing guidance.
For clinicians, Mana Medical calculates a Patient Stability Index and ranks enrolled patients by who may need attention, while also preparing monitoring documentation aligned with US Remote Therapeutic Monitoring reimbursement.
Building AI vision and robotics for hospital sterile-processing workflows.
- Country
Germany- Founded
- 2024
- Sector
- Medtech
- Funding stage
- Seed or earlier
Why enamentis stands out
Cir.Log is already live at three hospitals in Germany and Austria and integrates directly with NEXUS EuroSDS sterile-processing software. enamentis also leads a €2.87 million federally funded SteriBot consortium.
The startup is applying computer vision to a high-volume hospital workflow where every tray already requires identification, counting and verification. The product strengthens an existing sterile-processing task rather than creating a parallel system.
What enamentis is building
Cir.Log is an AI camera mounted above existing sterile-processing workstations. It identifies, counts and documents surgical instruments without requiring tags or markers and checks trays against pack lists.
enamentis is extending the same computer-vision layer into Steri.Bot robotics for broader automation of repetitive sterile-processing tasks.
Helping people track and manage blood pressure at home with reminders and reports.
- Country
- United Kingdom
- Founded
- 2024
- Sector
- Consumer health
- Funding stage
- Seed or earlier
- Founders
Why HealthNest stands out
HealthNest is already live on iOS and Android and was co-designed with more than 100 patients and healthcare professionals. It was also selected for DigitalHealth.London's 2025 Launchpad.
The product starts from a familiar primary-care task—home blood-pressure monitoring—and makes that existing workflow more structured, so readings are easier to interpret and bring back into clinical appointments.
What HealthNest is building
HealthNest combines guided blood-pressure logging, trend review, medication reminders, clinician-written education and exportable reports.
The current app gives patients a structured home-monitoring workflow, while the startup has outlined connected blood-pressure and ECG monitoring and a clinician offering as the next layer.
Building Noxxea, a digital medicine for chronic insomnia.
- Country
France- Founded
- 2023
- Sector
- Digital health
- Funding stage
- Seed or earlier
Why Di & Care stands out
Noxxea is CE-marked, prescribed by physicians and had reached more than 1,000 patients in 2026. In the REST-NOXXEA study, insomnia severity fell by 7.32 points and 79.3% of participants finished below the moderate-to-severe range.
That places Di & Care inside a prescription workflow rather than a general wellness model. The product fits an established clinical decision—prescribing treatment for chronic insomnia—while moving delivery into a digital format.
What Di & Care is building
Noxxea delivers a four-week digital cognitive behavioral therapy program for chronic insomnia on a smartphone.
The program structures sleep restriction, stimulus control and behavioral exercises into a prescription pathway supported by Di & Care's own doctor-facing platform.
Deal Sourcing for Investors
Looking for More Startups Like These?
DealBio helps investment teams discover, research, and monitor early-stage healthcare and life sciences startups aligned with their investment criteria.
Existing workflows can accelerate adoption
These startups enter care through very different routes, but none asks the health system to invent a new workflow from scratch. Each strengthens a task that already exists: ECG interpretation, rheumatology monitoring, sterile processing, home blood-pressure review or prescribed insomnia treatment.
For investors, that can reduce one layer of adoption risk. A startup still has to prove clinical value, usability and economics, but fitting into a familiar decision, reimbursement pathway or operational process can make the path to routine use more concrete than building an entirely new care behavior.
Methodology
DealBio selected these startups from its database of early-stage health and longevity startups, focusing on products that fit directly into an existing care workflow. The selection spans screening, monitoring, hospital operations, patient-facing follow-up and prescribed digital treatment.
DealBio builds its Startup Briefs using publicly available company materials, ecosystem sources, market references and professional profiles.